WAFA HMOUD: Open Payments
NPI 1902112063 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 19 payments from 11 companies in 2025. Trend: 2023 $1,977 · 2024 $1,335 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $277 |
| GlaxoSmithKline, LLC. | 3 | $159 |
| Amgen Inc. | 1 | $125 |
| Ardelyx, Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: JARDIANCE, AREXVY, REPATHA, IBSRELA, TRELEGY ELLIPTA, VOQUEZNA, ZORYVE, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
